We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$391M
AUM Growth
-$30.5M
Cap. Flow
-$19.7M
Cap. Flow %
-5.03%
Top 10 Hldgs %
48.1%
Holding
93
New
5
Increased
41
Reduced
33
Closed
7

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$7.56M
2
EXAS
Exact Sciences
EXAS
+$5.76M
3
UAA icon
Under Armour
UAA
+$5.07M
4
DORM icon
Dorman Products
DORM
+$2.13M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.55M

Sector Composition

Rank Sector Weight
1 Healthcare 34.12%
2 Technology 18.35%
3 Financials 13.13%
4 Consumer Discretionary 7.6%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
26
Salesforce
CRM
$155B
$4.84M 1.24%
32,587
-50
-0.2% -$7.6K
JNJ icon
27
Johnson & Johnson
JNJ
$608B
$4.79M 1.23%
36,778
-545
-1% -$71.8K
SIVB
28
DELISTED
SVB Financial Group
SIVB
$4.77M 1.22%
22,840
-910
-4% -$191K
DUK icon
29
Duke Energy
DUK
$96.6B
$4.66M 1.19%
48,093
+63
+0.1% +$5.73K
TEAM icon
30
Atlassian
TEAM
$27.3B
$4.58M 1.17%
36,475
+1,250
+4% +$170K
ABBV icon
31
AbbVie
ABBV
$431B
$4.54M 1.16%
60,014
-907
-1% -$62.2K
XOM icon
32
ExxonMobil
XOM
$634B
$4.53M 1.16%
63,432
-245
-0.4% -$17.7K
BABA icon
33
Alibaba
BABA
$310B
$4.35M 1.11%
26,019
+156
+0.6% +$26.8K
MMM icon
34
3M
MMM
$91.9B
$4.29M 1.1%
30,935
+253
+0.8% +$35.4K
GIS icon
35
General Mills
GIS
$19.1B
$4.15M 1.06%
75,314
+228
+0.3% +$12.3K
ALGN icon
36
Align Technology
ALGN
$12.3B
$3.87M 0.99%
21,384
-409
-2% -$85K
T icon
37
AT&T
T
$158B
$3.79M 0.97%
132,793
+764
+0.6% +$20.2K
IOVA icon
38
Iovance Biotherapeutics
IOVA
$1.96B
$3.36M 0.86%
+184,835
New +$4.09M
AMZN icon
39
Amazon
AMZN
$3T
$3.28M 0.84%
37,740
+100
+0.3% +$9.27K
BMY icon
40
Bristol-Myers Squibb
BMY
$131B
$3.2M 0.82%
63,163
+860
+1% +$40.4K
TFC icon
41
Truist Financial
TFC
$64.4B
$3.05M 0.78%
56,680
+365
+0.6% +$18.1K
MO icon
42
Altria Group
MO
$113B
$2.61M 0.67%
63,859
-440
-0.7% -$20.2K
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.5M 0.64%
37,734
-339
-0.9% -$22.8K
TWLO icon
44
Twilio
TWLO
$30B
$2.5M 0.64%
22,750
-45
-0.2% -$5.83K
DD icon
45
DuPont de Nemours
DD
$18.7B
$1.79M 0.46%
19,898
+596
+3% +$52.5K
GOOG icon
46
Alphabet (Google) Class C
GOOG
$4.57T
$1.46M 0.37%
23,960
-400
-2% -$23.7K
HDV
47
iShares Core High Dividend ETF
HDV
$14.7B
$1.36M 0.35%
72,225
+1,325
+2% +$24.9K
AMRN
48
Amarin Corp
AMRN
$294M
$1.3M 0.33%
4,283
+1,533
+56% +$535K
EW icon
49
Edwards Lifesciences
EW
$51.2B
$1.18M 0.3%
16,080
+5,310
+49% +$373K
AMGN icon
50
Amgen
AMGN
$207B
$1.09M 0.28%
5,609
+24
+0.4% +$4.61K

Similar funds

Biondo Investment Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Biondo Investment Advisors held 93 positions worth $391M, down 7.2% from $422M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors withdrew a net $19.7M in Q3 2019, closing 7 positions and reducing 33 holdings. Its most notable exit was Under Armour, an estimated $5.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors opened a new position in Iovance Biotherapeutics worth $3.36M.

  • Biondo Investment Advisors's largest Q3 2019 buy was Iovance Biotherapeutics: 184,835 shares worth $3.36M.
  • Biondo Investment Advisors added most to Boeing in Q3 2019, an estimated $997K increase.
  • Biondo Investment Advisors's biggest Q3 2019 reduction was Mastercard, cutting an estimated $7.56M.
  • Biondo Investment Advisors fully exited Under Armour in Q3 2019, selling an estimated $5.07M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $391M portfolio in Q3 2019.
  • Biondo Investment Advisors opened 5 new positions and closed 7 in Q3 2019.
  • Biondo Investment Advisors's portfolio value fell 7.2% quarter-over-quarter to $391M.

Based on Biondo Investment Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.